List of Excipients in API difluprednate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing difluprednate
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation | DUREZOL | difluprednate | 0078-0862 | BORIC ACID | |
Novartis Pharmaceuticals Corporation | DUREZOL | difluprednate | 0078-0862 | CASTOR OIL | |
Novartis Pharmaceuticals Corporation | DUREZOL | difluprednate | 0078-0862 | EDETATE DISODIUM | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing difluprednate
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Cipla USA Inc | difluprednate | 69097-341 | BORIC ACID |
Cipla USA Inc | difluprednate | 69097-341 | CASTOR OIL |
Cipla USA Inc | difluprednate | 69097-341 | EDETATE DISODIUM |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for difluprednate
Excipient focus: BORIC ACID
difluprednate drug variants containing BORIC ACID
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | difluprednate | 0078-0862 |
Cipla USA Inc | difluprednate | 69097-341 |
Exelan Pharmaceuticals Inc | difluprednate | 76282-708 |
>Company | >Ingredient | >NDC |
difluprednate drug variants not containing BORIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CASTOR OIL
difluprednate drug variants containing CASTOR OIL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | difluprednate | 0078-0862 |
Cipla USA Inc | difluprednate | 69097-341 |
Exelan Pharmaceuticals Inc | difluprednate | 76282-708 |
>Company | >Ingredient | >NDC |
difluprednate drug variants not containing CASTOR OIL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
difluprednate drug variants containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | difluprednate | 0078-0862 |
Cipla USA Inc | difluprednate | 69097-341 |
Exelan Pharmaceuticals Inc | difluprednate | 76282-708 |
>Company | >Ingredient | >NDC |
difluprednate drug variants not containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
difluprednate drug variants containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | difluprednate | 0078-0862 |
Cipla USA Inc | difluprednate | 69097-341 |
Exelan Pharmaceuticals Inc | difluprednate | 76282-708 |
>Company | >Ingredient | >NDC |
difluprednate drug variants not containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
difluprednate drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | difluprednate | 0078-0862 |
Cipla USA Inc | difluprednate | 69097-341 |
Exelan Pharmaceuticals Inc | difluprednate | 76282-708 |
>Company | >Ingredient | >NDC |
difluprednate drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
difluprednate drug variants containing SODIUM ACETATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | difluprednate | 0078-0862 |
Cipla USA Inc | difluprednate | 69097-341 |
Exelan Pharmaceuticals Inc | difluprednate | 76282-708 |
>Company | >Ingredient | >NDC |
difluprednate drug variants not containing SODIUM ACETATE
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | difluprednate ophthalmic | 43598-588 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE ANHYDROUS
difluprednate drug variants containing SODIUM ACETATE ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | difluprednate ophthalmic | 43598-588 |
>Company | >Ingredient | >NDC |
difluprednate drug variants not containing SODIUM ACETATE ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | difluprednate | 0078-0862 |
Cipla USA Inc | difluprednate | 69097-341 |
Exelan Pharmaceuticals Inc | difluprednate | 76282-708 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
difluprednate drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | difluprednate | 0078-0862 |
Cipla USA Inc | difluprednate | 69097-341 |
Exelan Pharmaceuticals Inc | difluprednate | 76282-708 |
>Company | >Ingredient | >NDC |
difluprednate drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SORBIC ACID
difluprednate drug variants containing SORBIC ACID
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | difluprednate | 0078-0862 |
Cipla USA Inc | difluprednate | 69097-341 |
Exelan Pharmaceuticals Inc | difluprednate | 76282-708 |
>Company | >Ingredient | >NDC |
difluprednate drug variants not containing SORBIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
difluprednate drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | difluprednate | 0078-0862 |
Cipla USA Inc | difluprednate | 69097-341 |
Exelan Pharmaceuticals Inc | difluprednate | 76282-708 |
>Company | >Ingredient | >NDC |
difluprednate drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.